INFL

Monday, July 30, 2012

Use natural remedies to quit smoking


Use natural remedies to quit smoking


(NaturalNews) Smoking is more than just a bad habit; it's an addiction. Governments try to fight smoking by making policies to raise taxes and the price of cigarettes so fewer people can afford them. This might work for some, but for people who are truly addicted, real help to break the addiction is needed. Herbs, natural chemicals and support groups can help people quit smoking naturally.


Herbal remedies for smoking cessation

There are a variety of herbs and supplements that can help people stop smoking. Some herbs to consider include lobelia for cigarette cravings, ginger root for nausea, St. John's Wort for depression, passion flower for irritability, and rhodiola for energy.

Rhodiola extract in the mornings can increase dopamine receptors. Dopamine is a hormone associated with mood. Too little dopamine can lead to anxiety and depression. Increasing dopamine receptors and uptake can make people feel happier, more energetic and less like smoking a cigarette.

People often feel nauseated when they are in withdrawal from nicotine. Ginger root may reduce nausea. Lobelia can be toxic so caution is needed when using.

Oats

Oats are a heart healthy food that is high in fiber, omega-3 fatty acids, potassium, and folate. Eating oats can help lower levels of bad cholesterol and keep arteries clear, which helps to lower risk of heart disease. They also contain chemicals called avenathramides that can reduce stress, strengthen the nervous system, fight free radials, and combat high blood pressure. All of these benefits can be crucial for smokers who are at a higher risk for heart disease.

Oats can also directly help smokers quit. An extract derived from green oats can ease withdrawal symptoms and help to decrease cigarette cravings.

Herbal cigarettes

Herbal cigarettes can replace regular cigarettes and help break the addiction. Smokers become used to reaching for a cigarette in certain situations and at specific times during the day. Sometimes a cigarette is about familiarity or comfort more than nicotine. Herbal cigarettes contain fewer chemicals and carcinogens in regular cigarettes. People can substitute herbal cigarettes to meet their psychological need for a smoke without compromising their health.

The main benefits of herbal cigarettes are that they are not additive. These cigarettes contain zero nicotine. They are made with herbs such as mint, cinnamon, clover, cornsilk, licorice or lemongrass. They also have some carcinogens so they should only be used as a short-term aide to break the nicotine habit and not long-term.

Free support

The American Lung Association has a free online program called Freedom from Smoking Online that offers assistance to people looking to quit smoking. People can also call 1-800-QUIT-NOW or go to Nicotine Anonymous meetings for support and information.

Sources for this article include:

http://www.helpguide.org/mental/quit_smoking_cessation.htm
http://www.stopsmoking.net/natural-quit.html
http://www.ehow.com
http://www.health.com/health/gallery/0,,20307113,00.html
http://naturalhealingtipsblog.blogspot.com

About the author:
Sarka-Jonae Miller is a health writer and novelist. She was certified as a personal fitness trainer through the National Academy of Sports Medicine and the Aerobics and Fitness Association of America. She also worked as a massage therapist, group exercise instructor and assistant martial arts instructor. 

Get more health and wellness tips on Sarka's blog, www.naturalhealingtipsblog.com

Connect with Sarka on Facebook http://www.facebook.com/pages/Sarka-Jonae-Miller/168691386526181
or on Twitter @sarkajonae

Learn more: http://www.naturalnews.com/036620_natural_remedies_quit_smoking_herbal.html#ixzz22DJxiuFx

Alternating hemiplegia of childhood (AHC)


Gene Discovery Set to Help With Mysterious Paralysis of Childhood

ScienceDaily (July 29, 2012) — Alternating hemiplegia of childhood (AHC) is a very rare disorder that causes paralysis that freezes one side of the body and then the other in devastating bouts that arise at unpredictable intervals. Seizures, learning disabilities and difficulty walking are common among patients with this diagnosis.

http://icare4autism.files.wordpress.com/2008/11/gene_system.jpg?w=71&h=96

Researchers at Duke University Medical Center have now discovered that mutations in one gene cause the disease in the majority of patients with a diagnosis of AHC, and because of the root problem they discovered, a treatment may become possible.
The study was published online on July 29 in Nature Genetics.
AHC is almost always a sporadic disease, which means that typically no one else in the family has the disease, said Erin Heinzen, Ph.D., co-author of the study and Assistant Professor of Medicine in the Section of Medical Genetics. "Knowing that we were looking for genetic mutations in children with this disease that were absent in the healthy parents, we carefully compared the genomes of seven AHC patients and their unaffected parents. When we found new mutations in all seven children in the same gene we knew we had found the cause of this disease."
All of the mutations were found in a gene that encodes ATP1A3, one piece of a key transporter molecule that normally would move sodium and potassium ions across a channel between neurons (nerve cells) to regulate brain activity.
In a remarkably broad international collaborative effort, the authors partnered with three family foundations (USA, Italy and France), including scientists from 13 different countries, to study an additional 95 patients and showed over 75 percent had disease-causing mutations in the gene for ATP1A3.
"This study is an excellent example of how genetic research conducted on a world-wide scale really can make a difference for such a rare disorder as AHC," said Arn van den Maagdenberg, Ph.D., and co-author on the study and geneticist from Leiden University Medical Centre in the Netherlands. "It truly was an effort from many research groups that led to this remarkable discovery."
"This kind of discovery really brings home just what the human genome project and next-generation sequencing have made possible," said David Goldstein, Ph.D., Director of the Duke Center for Human Genome Variation and co-senior author on the study. "For a disease like this one with virtually no large families to study, it would have been very difficult to find the gene before next-generation sequencing.
"Ideally what you want from a study like this is a clear indication of how the mutations change protein function so you know how to screen for drugs that will restore normal function or compensate for the dysfunction," said Goldstein, who is also a Professor in Duke Molecular Genetics and Microbiology. "While there is considerably more work to do, our initial evaluation of the mutations suggests that they may alter the behavior of the transporter pump as opposed to reducing its activity, as do other mutations in the gene that cause a less severe neurological disease."
Co-senior author Mohamad Mikati, M.D., Professor of Pediatrics and of Neurobiology, and Chief of Pediatric Neurology at Duke, said, "Many years ago my work with other collaborators on a family with this disease proved that AHC can be caused by genetic factors, but until now we did not know the underlying gene abnormality.
"The finding that ATP1A3 mutations cause AHC will increase awareness of the disease and the ability to accurately diagnose patients," Mikati said. "While it may take a while for novel drugs to be developed to better treat this disease, we will see an immediate impact through specific testing for mutations in this gene when we suspect a case of AHC. This direct testing will prevent misdiagnoses that too often have caused patients to be treated with inappropriate medications."
Other authors worked at the University of Utah, Salt Lake City; Università Cattolica Sacro Cuore, Rome; UPMC Univ Paris, INSERM, CNRS and Groupe Hospitalier de la Pitié-Salpêtrière, in Paris; Leiden University Medical Centre, Leiden, The Netherlands; University of Melbourne, Melbourne, Australia; University Hospitals of Lyon, France; University of Chicago, Illinois; University of California, San Francisco; Rijnland Hospital, Leiderdorp, The Netherlands; Sydney Children's Hospital, Randwick, and University of Sydney, New South Wales, Australia; Royal Hobart Hospital, Hobart, Australia; Our Lady's Children's Hospital, Crumlin, and the Childrens University Hospital, Dublin, Ireland; Rigshospitalet, University of Copenhagen; CRNL, CNRS INSERM, in Lyon, France; and UCL Institute of Neurology, London.
Story Source:
The above story is reprinted from materials provided byDuke University Medical Center.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:
  1. Erin L Heinzen et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhoodNature Genetics, 2012; DOI: 10.1038/ng.2358

Kidney Cancer Vaccine


Kidney Cancer Vaccine Successful in Clinical Trials

ScienceDaily (July 27, 2012) — Researchers at the University of Tübingen and immatics biotechnologies GmbH -- a start-up by Tübingen scientists -- have published the results of two clinical studies using the kidney-cancer vaccine IMA901 in the latest edition ofNature Medicine.

http://www.onlinecancerguide.com/blog/kidney-cancer/vaccination-for-kidney-cancer-more-information/

IMA901 is used to treat patients with cancer of the kidneys. It is composed of ten synthetic tumor-associated peptides (TUMAPs), which activate the body's own killer T-cells against the tumor. Unlike chemotherapy, this process targets the body's immune responses and mobilizes them to attack the cancer. The studies show that this active immunization against cancer can be successful and extend the life of a patient for longer than even the latest chemotherapy techniques -- with far fewer side-effects.
Prof. Dr. Hans-Georg Rammensee, head of Immunology at the University of Tübingen and co-founder of immatics biotechnologies, says: "This work is a milestone in the development of cancer immune therapies. The principle applied here -- of active immunization against cancer antigens previously identified in cancer cells -- can be used against practically all types of cancer. University of Tübingen researchers have published similarly successful clinical studies in the case of bowel cancer, also in collaboration with immatics, and prostate cancer. Immatics is currently carrying out studies on treatments for glioblastoma [a common and malignant brain tumor] and further studies for treating liver cancer and ovarian carcinoma are in the pipeline."
Prof. Dr. Arnulf Stenzl, head of Urology at the University Hospitals, who supervised the clinical studies, explains: "All of the medications previously used have brought about a clear improvement in reducing tumor growth in cancer of the kidneys, but they did not lead to the desired extension of the patient's life and certainly did not cure the patient. So from the clinical point of view, the further development by immatics of active immunization in combination with a low dose of one-off chemotherapy is a significant step in the treatment of kidney cell carcinoma -- and possibly other malignant tumors as well."
One particular aspect of this kidney cancer study is its uniquely exhaustive analysis of the immune response against the cancer antigens -- done with the help of biomarkers. In particular, the characteristics of the white blood cells involved were precisely detailed during the course of the immunization. Complex logistics were required to get these cells frozen and transported to Tübingen from study centers all over Europe, while ensuring they were in a fit state to be analyzed.
The study shows that in kidney-cancer patients with documented T-cell reactions against two or more tumor-associated peptides, the immune reaction and clinical progress were clearly linked. That confirms the hypothesis that cancer treatments can be further developed by broadly activating the immune system against various target structures on the surface of the tumor. The article also describes the researchers' aims of identifying biomarkers which could help give a more accurate prediction of how long certain groups of patients may live after being treated with IMA901. An analysis of more than 300 potential biomarkers turned up a number of them which are currently being tested in a new phase-3 study by immatics for their ability to show an immune response and the extension of patient life after treatment with IMA901.
Story Source:
The above story is reprinted from materials provided byUniversitaet Tübingen.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:
  1. Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, Anna Pluzanska, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Regina Mendrzyk, Norbert Hilf, Oliver Schoor, Jens Fritsche, Andrea Mahr, Dominik Maurer, Verona Vass, Claudia Trautwein, Peter Lewandrowski, Christian Flohr, Heike Pohla, Janusz J Stanczak, Vincenzo Bronte, Susanna Mandruzzato, Tilo Biedermann, Graham Pawelec, Evelyna Derhovanessian, Hisakazu Yamagishi, Tsuneharu Miki, Fumiya Hongo, Natsuki Takaha, Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanovic, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, Hans-Georg Rammensee, Carsten Reinhardt, Harpreet Singh-Jasuja. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalNature Medicine, 2012; DOI:10.1038/nm.2883

Saturday, July 28, 2012

Cinnamon beats Alzheimers


Cinnamon beats Alzheimers


(NaturalNews) The miracle spice cinnamon is the scented bark of a tropical evergreen tree, native to India and Sri Lanka. Cinnamon comes from an evergreen tree in Southeast Asia and is cultivated widely in Vietnam, China, Burma, and Laos for its bark and the oil processed from the bark. Once upon a time in ancient Rome, cinnamon was worth more than silver.

Cinnamon is harvested from the inner bark of the tree branches after scraping off the corky outer layer and then drying the bark. As it dries, the bark curls up into quills which are then cut into sticks to be ground into the spice form. Full of calcium and fiber, cinnamon is one of the oldest known spices, it is mentioned in the Bible and was used in ancient Egypt as medicine, beverage flavoring and an embalming agent.


According to traditional Chinese medicine, cinnamon helps improve the body's "fire."

Cinnamon - Not just a spice!

Professor Daniel Fung, an expert in food science at Kansas State University, says cinnamon contains a compound that has the ability to kill bacteria. "If cinnamon can knock out E.coli 0157:H7, one of the most virulent food-borne microorganisms that exists today, it will certainly have antimicrobial effects on other common food-borne bacteria such as Salmonella and Campylobacter."

Now researchers from Tel Aviv University found that extracts from cinnamon bark inhibit the toxic amyloid polypeptide oligomers and fibrils that have been found in Alzheimer's Disease (AD) brain plaque formations. In animal models of Alzheimer's, cinnamon reduced s-amyloid plaques associated with the pathology of AD. Reduction of these proteins can improve mental cognition. In one model, cinnamon extract resolved AD associate reduced longevity, helped recover locomotion defects and completely abolished tetrameric species of plaque in the brain.

Other benefits of cinnamon are: anti-microbial actions, blood sugar balancing, improving colon health, boosting brain function. Cinnamaldehyde in cinnamon has been well researched for its effects on blood platelets which help the blood clot to stop bleeding. Platelets can also cause strokes if they clump together too much. Cinnamon has been shown to help prevent this deadly clumping. Cinnamon will stop vomiting and relieve feelings of nausea. Cinnamon also helps slow tumor growth while inhibiting inflammatory markers connected to cellular proliferation.

In a recent study, people reduced their blood sugar levels by as much as 29 percent with cinnamon in just 40 days. That's with NO drugs, NO diet changes - just plain old cinnamon!

Study volunteers who took a cinnamon extract showed significant decreases in fasting blood glucose and increases in lean muscle mass compared with the placebo group. Pre and post study analysis of the extract group revealed a statistically significant decrease in body fat and blood pressure.

Research found that cinnamon can have favorable effects on brain function. Participants in a study chewed cinnamon gum or even just smelled the sweet spice. Cognitive tests revealed that subjects who used cinnamon had better memory functions and could process information more quickly.

What kind and how much

Which is best: Ceylon cinnamon, Saigon cinnamon, cinnamomum zeylanicum or regular grocery store variety cinnamon? Interestingly, the grocery store variety known as cinnamomum cassia works the best in most research studies and clinical trials.

Drink cinnamon in tea or sprinkle a little cinnamon on your toast, cereal, oatmeal, or sliced apples. It not only tastes good, it lowers your blood sugar!

Taking two 500 mg capsules of cinnamon a day will help good cholesterol levels and taking two capsules with each meal can make a big difference in blood sugar and insulin levels for diabetics.

Sources for this article

http://www.plosone.org
http://news.bbc.co.uk/2/hi/health/413533.stm
http://www.prevention.com/health/brain-games/memory-and-cinnamon-gum
Solomon TP, Blannin AK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol. 2009 Apr;105(6):969-76. Epub 2009 Jan 22

About the author:
Craig Stellpflug is a Cancer Nutrition Specialist, Lifestyle Coach and Neuro Development Consultant at Healing Pathways Medical Clinic, Scottsdale, AZ. http://www.healingpathwayscancerclinic.com/ With 17 years of clinical experience working with both brain disorders and cancer, Craig has seen first-hand the devastating effects of vaccines and pharmaceuticals on the human body and has come to the conclusion that a natural lifestyle and natural remedies are the true answers to health and vibrant living. You can find his daily health blog at www.blog.realhealthtalk.com and his articles and radio show archives at www.realhealthtalk.com

Learn more: http://www.naturalnews.com/036607_cinnamon_Alzheimers_prevention.html#ixzz221VIyZFa

Thursday, July 26, 2012

Fast Food Diet

American fast food diet unleashes disease epidemic sweeping across Asia


(NaturalNews) Though increasingly looked down upon here in the U.S. as a sign of slothfulness and low socioeconomic status, routine fast food consumption in some parts of the world is actually considered to be culturally desirable. But as foreigners progressively adopt the American fast-food lifestyle in place of their own native foods, rates of chronic disease are skyrocketing, including in East and Southeast Asia where diabetes and heart disease rates are off the charts.

According to a recent study published in the journal Circulation, globalization continues to usher U.S.-style fast food into East Asian countries like Singapore, Malaysia, and Cambodia, where natives, especially those from the younger generations, are quickly adopting things like hamburgers and fries in place of their traditional fare. And based on the data, this Western fast food craze is responsible for a significant uptick in cases of diabetes and heart disease.


For their study, a team of researchers from the University of Minnesota (UM) School of Public Health analyzed data on more than 60,000 Singaporeans of Chinese descent. Study participants were interviewed beginning in the 1990s, and followed and tracked for about ten years. At the end of the study, researchers compared the participants' eating habits to rates of chronic disease.

They found that, among participants who were between the ages of 45 and 74 at the beginning of the study, 1,397 died of cardiac illness by the end of the study, and 2,252 developed type-2 diabetes. Those who ate fast food two or more times a week were 27 percent more likely than others to develop type-2 diabetes, while the same group was 56 percent more likely to die from cardiac illness.

Those who ate American-style fast food four or more times a week were even worse off, as they were nearly twice as likely to die of cardiac illness than participants who ate no fast food. And interestingly, it was only American-style fast food that was linked to the disease uptick -- native fast foods like dim sum, noodles, and dumplings did not appear to increase the participants' risk of developing chronic disease.

"Many cultures welcome (Western fast food) because it's a sign they're developing their economies," says Andrew Adegaard, author of the study from the UM School of Public Health. "But while it may be desirable from a cultural standpoint, from a health perspective there may be a cost. It wasn't their own snacks that was putting them at increased risk, but American-style fast food."

Sources for this article include:

http://www.health.umn.edu

http://www.reuters.com

http://www.scientificamerican.com

Learn more: http://www.naturalnews.com/036595_fast_food_chronic_disease_epidemic.html#ixzz21o0IytPt

Vitamin D as Anti-Cancer Drug

Vitamin D revealed to be miracle anti-cancer 'drug' with astonishing chemical properties


(NaturalNews) A new study published this month finds that the hormonally active form of vitamin D, Calcitriol 1,25-dihydroxyvitamin D(3), inhibits the growth of many kinds of cancerous cells, including breast cancer, indicating that vitamin D3 can be useful in treating and even preventing a variety of cancers. Authors of the study said that caner cell growth is inhibited by "anticancer actions including cell cycle arrest, promotion of apoptosis and inhibition of invasion, metastasis, and angiogenesis." Vitamin D's anti-inflammatory properties and interference with estrogen synthesis further explains its anti-tumor properties.



Two studies from 2007 used meta-analysis, which combines data from multiple reports, to find that therapeutic doses of vitamin D could prevent up to half of all cases of breast cancer, and two-thirds of all cases of colorectal cancer in the United States. The studies showed a direct correlation between blood levels of vitamin D and cancer. Those with the highest blood levels were found to be at the lowest risk, and the lowest blood levels at the highest risk.

Many sources still try to cast a shadow on the effectiveness of vitamin D, citing that a specific dose strength has not yet been established, and needs more research. It likely won't be narrowed down to a one-size-fits-all dose, because every body is different, and if it were, it wouldn't be as effective. One other thing that may be giving varied results regarding dosing is the source of vitamin D used - it varies from study to study. Typically, higher doses are required of synthetic sources to increase blood levels, and they don't generally have the same effect as natural sources.

Vitamin D facts

The "sunshine" vitamin, vitamin D is fat-soluble vitamin required for the absorption and utilization of calcium and phosphorous. It protects against muscle weakness, regulates heartbeat, is necessary for normal blood clotting and thyroid function, and regulates more than 2,000 genes, affecting the proliferation and death of cells.

Vitamin D comes in several forms. The kind that comes from food is D2. There is a synthetic form, D5. The most active is the most natural kind, D3. It is synthesized in the skin in response to the sun's ultraviolet rays. There is a cholesterol compound in the skin that is a precursor of vitamin D. The D we get from food and supplements is not fully active until it goes through the liver and kidneys, where it is converted, then it circulates through the blood like a hormone.

According to Bach, problems from deficiency may include: heart disease, birth defects, depression, hypertension, stroke, dementia, fibromyalgia, impaired bone mineralization, skin, breast, prostate and other cancers, multiple sclerosis, insomnia, eye problems, problems with pregnancy, and other chronic diseases. It is estimated that more than one billion people worldwide, and 77 percent of Americans, are deficient in vitamin D.

It is not possible for most people to consume enough vitamin D thorough diet alone. It is found in fatty saltwater fish and fish liver oils, such as halibut, salmon, sardines, and cod liver oil. It is also added (fortified) to diary and eggs, so you'll find it in things like milk, yogurt, and butter. Other foods that have vitamin D include dandelion greens, oatmeal, cereals, and sweet potatoes.

Having a healthy and balanced diet can prevent cancer, and the need for prescriptions that contribute to cancer, such as cholesterol reducing drugs that inhibit vitamin D absorption from the sun. Even the National Cancer Institute estimates that 80 percent of cancer cases could be prevented. Most people supplement to get enough vitamin D. The recommended doses are generally not enough to address health problems. Be sure your supplements come from whole food vitamins so that higher doses won't be detrimental to your health, as they might from synthetic vitamin sources.

Eating good food, limiting unhealthy food and substances, getting exercise, and soaking up a bit of sun are critical to happiness and lasting health. So get out there and have fun - and help prevent cancer while you're at it!

Sources for this article include:

http://www.foodconsumer.org

http://www.sciencedaily.com/releases/2007/02/070206100608.htm

Balch, Phyllis, CNC. Prescription for Nutritional Healing. p. 21.

http://www.naturalnews.com/035063_vitamin_D_cancer_facts.html

Learn more: http://www.naturalnews.com/036597_vitamin_D_anti-cancer_drug.html#ixzz21nxgrxlh

Tuesday, July 24, 2012

Bionics


Bionics

Bionics

bi-on-ics

Etymology: from bi (as in “life”) + onics (as in “electronics”); the study of mechanical systems that function like living organisms or parts of living organisms

By Josh Fischman
Photograph by Mark Thiessen
Amanda Kitts is mobbed by four- and five-year-olds as she enters the classroom at the Kiddie Kottage Learning Center near Knoxville, Tennessee. “Hey kids, how’re my babies today?” she says, patting shoulders and ruffling hair. Slender and energetic, she has operated this day-care center and two others for almost 20 years. She crouches down to talk to a small girl, putting her hands on her knees.
“The robot arm!” several kids cry.
“You remember this, huh?” says Kitts, holding out her left arm. She turns her hand palm up. There is a soft whirring sound. If you weren’t paying close attention, you’d miss it. She bends her elbow, accompanied by more whirring.
“Make it do something silly!” one girl says.
“Silly? Remember how I can shake your hand?” Kitts says, extending her arm and rotating her wrist. A boy reaches out, hesitantly, to touch her fingers. What he brushes against is flesh-colored plastic, fingers curved slightly inward. Underneath are three motors, a metal frame, and a network of sophisticated electronics. The assembly is topped by a white plastic cup midway up Kitts’s biceps, encircling a stump that is almost all that remains from the arm she lost in a car accident in 2006.
Almost all, but not quite. Within her brain, below the level of consciousness, lives an intact image of that arm, a phantom. When Kitts thinks about flexing her elbow, the phantom moves. Impulses racing down from her brain are picked up by electrode sensors in the white cup and converted into signals that turn motors, and the artificial elbow bends.
“I don’t really think about it. I just move it,” says the 40-year-old, who uses both this standard model and a more experimental arm with even more control. “After my accident I felt lost, and I didn’t understand why God would do such a terrible thing to me. These days I’m just excited all the time, because they keep on improving the arm. One day I’ll be able to feel things with it and clap my hands together in time to the songs my kids are singing.”
Kitts is living proof that, even though the flesh and bone may be damaged or gone, the nerves and parts of the brain that once controlled it live on. In many patients, they sit there waiting to communicate—dangling telephone wires, severed from a handset. With microscopic electrodes and surgical wizardry, doctors have begun to connect these parts in other patients to devices such as cameras and microphones and motors. As a result, the blind can see, the deaf can hear, and Amanda Kitts can fold her shirts.
Kitts is one of “tomorrow’s people,” a group whose missing or ruined body parts are being replaced by devices embedded in their nervous systems that respond to commands from their brains. The machines they use are called neural prostheses or—as scientists have become more comfortable with a term made popular by science fiction writers—bionics. Eric Schremp, who has been a quadriplegic since he shattered his neck during a swimming pool dive in 1992, now has an electronic device under his skin that lets him move his fingers to grip a fork. Jo Ann Lewis, a blind woman, can see the shapes of trees with the help of a tiny camera that communicates with her optic nerve. And Tammy Kenny can speak to her 18-month-old son, Aiden, and he can reply, because the boy, born deaf, has 22 electrodes inside his ear that change sounds picked up by a microphone into signals his auditory nerve can understand.
The work is extremely delicate, a series of trials filled with many errors. As scientists have learned that it’s possible to link machine and mind, they have also learned how difficult it is to maintain that connection. If the cup atop Kitts’s arm shifts just slightly, for instance, she might not be able to close her fingers. Still, bionics represents a big leap forward, enabling researchers to give people back much more of what they’ve lost than was ever possible before.
“That’s really what this work is about: restoration,” says Joseph Pancrazio, program director for neural engineering at the National Institute of Neurological Disorders and Stroke. “When a person with a spinal-cord injury can be in a restaurant, feeding himself, and no one else notices, that is my definition of success.”
A history of body-restoration attempts, in the form of man-made hands and legs and feet, lines the shelves in Robert Lipschutz’s office at the Rehabilitation Institute of Chicago (RIC). “The basic technology of prosthetic arms hasn’t changed much in the last hundred years,” he says. “Materials are different, so we use plastic instead of leather, but the basic idea has been the same: hooks and hinges moved by cables or motors, controlled by levers. A lot of amputees coming back from Iraq get devices like these. Here, try this on.” Lipschutz drags a plastic shell off one of his shelves.
It turns out to be a left shoulder and arm. The shoulder part is a kind of breastplate, secured across the chest by a harness. The arm, hinged at the shoulder and elbow, ends in a metal pincer. To extend the arm, you twist your head to the left and press a lever with your chin, and use a little body English to swing the limb out. It is as awkward as it sounds. And heavy. After 20 minutes your neck hurts from the odd posture and the effort of pressing the levers. Many amputees end up putting such arms aside.
“It’s hard for me to give people these devices sometimes,” Lipschutz says, “because we just don’t know if they will really help.” What could help more, he and others at RIC think, is the kind of prosthesis Amanda Kitts has volunteered to test—one controlled by the brain, not by body parts that normally have nothing to do with moving the hand. A technique called targeted muscle reinnervation uses nerves remaining after an amputation to control an artificial limb. It was first tried in a patient in 2002. Four years later Tommy Kitts, Amanda’s husband, read about it on the Internet as his wife lay in a hospital bed after her accident. The truck that had crushed her car had also crushed her arm, from just above the elbow down.
“I was angry, sad, depressed. I just couldn’t accept it,” she says. But what Tommy told her about the Chicago arm sounded hopeful. “It seemed like the best option out there, a lot better than motors and switches,” Tommy says. “Amanda actually got excited about it.” Soon they were on a plane to Illinois.
Todd Kuiken, a physician and biomedical engineer at RIC, was the person responsible for what the institute had begun calling the “bionic arm.” He knew that nerves in an amputee’s stump could still carry signals from the brain. And he knew that a computer in a prosthesis could direct electric motors to move the limb. The problem was making the connection. Nerves conduct electricity, but they can't be spliced together with a computer cable. (Nerve fibers and metal wires don’t get along well. And an open wound where a wire enters the body would be a dangerous avenue for infections.)
Kuiken needed an amplifier to boost the signals from the nerves, avoiding the need for a direct splice. He found one in muscles. When muscles contract, they give off an electrical burst strong enough to be detected by an electrode placed on the skin. He developed a technique to reroute severed nerves from their old, damaged spots to other muscles that could give their signals the proper boost.
In October 2006 Kuiken set about rewiring Amanda Kitts. The first step was to salvage major nerves that once went all the way down her arm. “These are the same nerves that work the arm and hand, but we had to create four different muscle areas to lead them to,” Kuiken says. The nerves started in Kitts’s brain, in the motor cortex, which holds a rough map of the body, but they stopped at the end of her stump—the disconnected telephone wires. In an intricate operation, a surgeon rerouted those nerves to different regions of Kitts’s upper-arm muscles. For months the nerves grew, millimeter by millimeter, moving deeper into their new homes.
“At three months I started feeling little tingles and twitches,” says Kitts. “By four months I could actually feel different parts of my hand when I touched my upper arm. I could touch it in different places and feel different fingers.” What she was feeling were parts of the phantom arm that were mapped into her brain, now reconnected to flesh. When Kitts thought about moving those phantom fingers, her real upper-arm muscles contracted.
A month later she was fitted with her first bionic arm, which had electrodes in the cup around the stump to pick up the signals from the muscles. Now the challenge was to convert those signals into commands to move the elbow and hand. A storm of electrical noise was coming from the small region on Kitts’s arm. Somewhere in there was the signal that meant “straighten the elbow” or “turn the wrist.” A microprocessor housed in the prosthesis had to be programmed to fish out the right signal and send it to the right motor.
Finding these signals has been possible because of Kitts’s phantom arm. In a lab at the RIC Blair Lock, a research engineer, fine-tunes the programming. He has Kitts slide off the artificial arm so that he can cover her stump with electrodes. She stands in front of a large flat-panel TV screen that displays a disembodied, flesh-colored arm floating in blue space—a visualization of her phantom. Lock’s electrodes pick up commands from Kitts’s brain radiating down to her stump, and the virtual arm moves.
In a hushed voice, so as not to break her concentration, Lock asks Kitts to turn her hand, palm in. On-screen, the hand turns, palm in. “Now extend your wrist, palm up,” he says. The screen hand moves. “Is that better than last time?” she asks. “Oh yeah. Strong signals.” Kitts laughs. Now Lock asks her to line up her thumb alongside her fingers. The screen hand obliges. Kitts opens her eyes wide. “Wow. I didn’t even know I could do that!” Once the muscle signals associated with a particular movement are identified, the computer in the arm is programmed to look for them and respond by activating the correct motor.
Kitts practiced using her arm one floor below Kuiken’s office in an apartment set up by occupational therapists with everything a newly equipped amputee might ordinarily use. It has a kitchen with a stove, silverware in a drawer, a bed, a closet with hangers, a bathroom, stairs—things people use every day without a second thought but that pose huge obstacles to someone missing a limb. Watching Kitts make a peanut butter sandwich in the kitchen is a startling experience. With her sleeve rolled back to reveal the plastic cup, her motion is fluid. Her live arm holds a slice of bread, her artificial fingers close on a knife, the elbow flexes, and she swipes peanut butter back and forth.
“It wasn’t easy at first,” she says. “I would try to move it, and it wouldn’t always go where I wanted.” But she worked at it, and the more she used the arm, the more lifelike the motions felt. What Kitts would really like now is sensation. That would be a big help in many actions, including one of her favorites—gulping coffee.
“The problem with a paper coffee cup is that my hand will close until it gets a solid grip. But with a paper cup you never get a solid grip,” she says. “That happened at Starbucks once. It kept squeezing until the cup went ‘pop.’”
There’s a good chance she’ll get that sensation, says Kuiken, again thanks to her phantom. In partnership with bioengineers at the Johns Hopkins University Applied Physics Laboratory, RIC has been developing a new prototype for Kitts and other patients that not only has more flexibility—more motors and joints—but also has pressure-sensing pads on the fingertips. The pads are connected to small, piston-like rods that poke into Kitts’s stump. The harder the pressure, the stronger the sensation in her phantom fingers.
“I can feel how hard I’m grabbing,” she says. She can also tell the difference between rubbing something rough, like sandpaper, and smooth, like glass, by how fast the rods vibrate. “I go up to Chicago to experiment with it, and I love it,” she says. “I want them to give it to me already so I can take it home. But it’s a lot more complicated than my take-home arm, so they don’t have it completely reliable yet.”
Eric Schremp, unlike Kitts, doesn’t need artificial hands. He just needs his natural ones to work. They haven’t done that on their own since Schremp broke his neck in 1992, leaving him a quadriplegic. Now, however, the 40-year-old Ohio man can grip a knife or a fork.
He can do this because of an implanted device developed by Hunter Peckham, a biomedical engineer at Case Western Reserve University in Cleveland. “Our goal is to restore hand grasping,” Peckham says. “Hand use is key to independence.”
Schremp’s finger muscles and the nerves that control them still exist, but the signals from his brain have been cut off at the neck. Peckham’s team ran eight micro-thin electrodes from Schremp’s chest under the skin of his right arm, ending at the finger muscles. When a muscle in his chest twitches, it triggers a signal that’s sent via a radio transmitter to a small computer hanging from his wheelchair. The computer interprets the signal and radios it back to a receiver implanted in his chest, where the signal is sent by wires down Schremp’s arm to his hand. There the signal tells his finger muscles to close in a grip—all within a microsecond.
“I can grab a fork and feed myself,” Schremp says. “That means a lot.”
About 250 people have been treated with this technique, which is still experimental. But another bionic device has shown that the marriage of mind and machine can be both powerful and enduring, having been implanted in nearly 200,000 people around the world during the past 30 years. That device is the cochlear implant, and Aiden Kenny is among the latest recipients. Tammy Kenny, his mother, remembers when, a year ago, she learned that her baby was beyond the help of hearing aids.
“I would just hold him in my arms and cry,” she says, “knowing he couldn’t hear me. How would he ever get to know me? One time, my husband banged pots together, hop�ing for a response." Aiden never heard the noise.
He hears banging pots now. In February 2009 surgeons at Johns Hopkins Hospital snaked thin lines with 22 electrodes into each cochlea, the part of the inner ear that normally detects sound vibrations. In Aiden, a microphone picks up sounds and sends signals to the electrodes, which pass them directly to the nerves.
“The day they turned on the implant, a month after surgery, we noticed he responded to sound,” Tammy Kenny says. “He turned at the sound of my voice. That was amazing.” Today, she says, with intensive therapy, he’s picking up language, quickly catching up to his hearing peers.
Bionic eyes may soon follow bionic ears. Jo Ann Lewis lost her sight years ago to retinitis pigmentosa, a degenerative disease that destroys light-detecting cells in the eyes called rods and cones. Lately, however, she has partially regained her vision as a result of research by Mark Humayun, an ophthalmologist at the University of Southern California and a company called Second Sight.
As is common with this disease, part of an inner layer of her retina had survived. This layer, filled with bipolar and ganglion cells, normally gathers signals from outer rods and cones and passes them to fibers that fuse into the optic nerve. No one knew what language the inner retina spoke or how to feed it images it could understand. But in 1992, Humayun began laying, for a short time, a tiny electrode array on the retinas of RP patients undergoing surgery for other reasons.
“We asked them to follow a dot, and they could,” he says. “They could see rows, and they could see columns.” After another decade of testing, Humayun and his colleagues developed a system they dubbed Argus. (Greek mythology. A giant. Hundreds of eyes.) Patients got a pair of dark glasses with a tiny video camera mounted on them, along with a radio transmitter. Video signals were beamed to a computer worn on a belt, translated to electrical impulse patterns understood by ganglion cells, and then beamed to a receiver resting behind the ear. From there a wire took them inside the eye, to a square array of 16 electrodes gently attached to the retinal surface. The impulses triggered the electrodes. The electrodes triggered the cells. Then the brain did the rest, enabling these first patients to see edges and some coarse shapes.
In the fall of 2006 Humayun, Second Sight, and an international team increased the electrodes in the array to 60. Like a camera with more pixels, the new array produced a sharper image. Lewis, from Rockwall, Texas, was among the first to get one. “Now I’m able to see silhouettes of trees again,” she says. “That’s one of the last things I remember seeing naturally. Today I can see limbs sticking out this way and that.”
Pushing the neural prosthetic concept further, researchers are beginning to use it on the brain itself. Scientists behind a project called BrainGate are attempting to wire the motor cortex of completely immobilized patients directly into a computer so that patients can move remote objects with their minds. So far, test subjects have been able to move a cursor around a computer screen. Researchers are even planning to develop an artificial hippocampus, the part of the brain that stores memories, with the intent of implanting it in people with memory loss.
Not everything will work perfectly. One of the four initial BrainGate patients decided to have the plug removed because it interfered with other medical devices. And Jo Ann Lewis says her vision isn’t good enough for her to safely cross a street. Today, however, Kitts has a new, more elastic cup atop her arm that better aligns electrodes with nerves that control the arm.
“It means I can do a lot more with the arm,” she says. “A new one up in Chicago lets me do lots of different hand grasps. I want that. I want to pick up pennies and hammers and toys with my kids.” These are reasonable hopes for a replacement part, Kuiken says. “We are giving people tools. They are better than what previously existed. But they are still crude, like a hammer, compared with the complexity of the human body. They can’t hold a candle to Mother Nature.”
Still, at least the people using the tools can grab the candle. And some can even see it flicker in the dark.
Source:
http://ngm.nationalgeographic.com/2010/01/bionics/fischman-text
http://ngm.nationalgeographic.com/2010/01/bionics/fischman-text/2
Josh Fischman is a senior editor for research and technology at the Chronicle of Higher Education. Mark Thiessen is aGeographic staff photographer.

Monday, July 23, 2012

Gene therapy


یورپ میں پہلی مرتبہ جینین کی مدد سے کیے جانے والے طریقۂ علاج کی منظوری دی جانے والی ہے جو طب کے میدان میں ایک سنگِ میل کی حیثیت رکھتا ہے۔
جین تھراپی میں مریض کے ڈی این اے کو تبدیل کرکے والدین سے بچوں میں منتقل ہونے والی پیدائشی 
بیماریوں کا علاج کیا جائے گا۔
یورپ کی دوا ساز ادارے نے نایاب جینیاتی بیماری کے لیے جس میں لوگ چکنائی کو مناسب طریقے سے ہضم نہیں کر پاتے یہ طریقہء علاج تجویز کیا ہے۔
یورپین کمیشن اب اس حوالےسے حتمی فیصلہ کرے گا۔

طریقہء علاج

جین تھراپی کا خیال بہت سادہ ہے۔ اگر کسی مریض کے جنیٹک کوڈ کے کسی حصے میں کوئی مسئلہ ہے تو جنیٹک کوڈ کے اس حصے کو تبدیل کر دیا جائے گا۔
تاہم درحقیقت یہ طریقہ اتنا آسان بھی نہیں ہے۔ امریکہ میں ایک نوجوان اس طریقۂ علاج کے دوران ہلاک ہو گیا تھا جبکہ کئی دوسرے مریض لیوکیمیا کا شکار ہو گئے تھے۔
امریکہ اور یورپ میں تحقیقاتی لیبارٹریز کے علاوہ یہ طریقۂ علاج کہیں اور میّسر نہیں ہے۔
یورپی دوا ساز ادارے کی انسانوں کے لیے دوا بنانے والے کمیٹی جسم میں چربی کو روکنے والے حیاتی کیمیا کی کمی کے لیے گلیبرا (Glybera) تجویز کرتی ہے۔ دس لاکھ میں سے کسی ایک انسان میں یہ کمی پائی جاتی ہے۔
انسانی جسم میں اس جین کی کمی سے خون میں چکنائی بڑھ جاتی ہے، پیٹ میں درد رہتا ہے اور لبلبے پر جان لیوا سوزش ہو جاتی ہے۔
اس حالت سے نمٹنے کا واحد طریقہ یہ ہے کہ انتہائی کم چکنائی والی خوراک لی جائے۔
تاہم جین تھراپی کا طریقۂ علاج صرف ان مریضوں میں تجویز کیا جاتا ہے جن میں لبلبے کی سوزش اس قدر بڑھ جاتی ہے کہ اسے خوراک کے ذریعے کنٹرول نہیں کیا جا سکتا۔
ادارے سے وابستہ ڈاکٹر تھامس سیلمنسن کا کہنا ہے کہ ’گیلبرا صرف ان لوگوں کو دی جاتی چاہیے جنہیں اس کی انتہائی ضرورت ہو۔‘
چین پہلا ملک ہے جہاں جین تھراپی پر سرکاری طور پر پابندی عائد کی گئی ہے۔

Sunday, July 22, 2012

Essential Fatty Acids

Essential Fatty Acids and the sun
(NaturalNews) Most of us are now aware of the importance of Essential Fatty Acids to our overall health and well being. What isn't so commonly discussed; however, is the relationship between EFAs and the sun.




Don't be afraid of the sun

It seems many people are so concerned with covering themselves up from any sun exposure that they are missing out on the important benefits of sunlight. Dr. Robert S. Stern, chair of the Department of Dermatology at Harvard Affiliated Beth Israel Deaconess Medical Center, calls them "solar-phobes." Let's be clear, too much sun exposure is associated with skin cancer and premature skin aging. The key is to find a balance.

Lack of sun exposure and Vitamin D deficiencies go hand-in-hand

Sun exposure is the only reliable way to generate vitamin D in the body. There is now clear evidence that vitamin D deficiencies are associated with an increased rate of various types of cancer. Vitamin D is one of the most powerful healing chemicals in your body, yet completely steering clear of the sun will all but guarantee that you won't get enough of it.

Mike Adams writes "Vitamin D prevents osteoporosis, depression, prostate cancer, breast cancer, and even affects diabetes and obesity. Vitamin D is perhaps the single most underrated nutrient in the world of nutrition."

Vitamin D isn't the only reason you need sunlight 

Many people are aware of the connection between vitamin D and the sun; however, what many people aren't aware of is that the heath benefits of EFAs and sunlight go hand-in-hand. Dr. Johana Budwig, seven-time Nobel Prize nominee and pioneer in Essential Fatty Acid research, says the sun's rays are very much in harmony with humans.

Budwig reported positive results in healing heart disease, arthritis, cancer and other common diseases with massive doses of EFAs. Budwig believed in the EFA-sun connection so strongly that she would have her patients lie in the sun after consuming large doses of EFAs. Not surprisingly, the patients reported feeling rejuvenated.

How does it all work?

Essential Fatty Acids are electron-rich oils which are compatible with solar rays. "Electron-rich highly unsaturated oils... increase the absorption, storage and utilization of the sun's energy" Dr. Budwig explains. What's more is that those who lack EFAs do not experience the same benefits from sun exposure.

We notice individuals in our time experiencing stress and decreased energy from exposure to the sun's energy, whereas others respond with dynamic improvement in all vital functions. There is now great cause to believe that the difference in these individuals is the intake of EFAs.

Sources for this article include:

http://www.naturalnews.com/003069_vitamin_D_deficiency.html

http://www.health.harvard.edu/fhg/updates/update0604d.shtml

http://www.regenerativenutrition.com/content.asp?id=64

About the author:
John Mckiernan is a health and fitness writer. He is the owner of Supplement Helper where he writes supplement reviews and more. He also manages CNA Info, a small blog that is aimed at answering questions for those interested in topics such as CNA classes online.

Learn more: http://www.naturalnews.com/036544_essential_fatty_acids_sun_exposure_vitamin_D.html#ixzz21Mmtvdfj

Saturday, July 21, 2012

Dental toxins

Seven questions to ask your dentist if you want to reduce dental toxins


(NaturalNews) Amalgam fillings are composed of mercury, silver, tin, copper and other trace metals. A growing body of evidence suggests that amalgam fillings contribute to many degenerative diseases and cancers. According to a report published by The International Academy of Oral Medicine and Toxicology, there are over 1000 tons of mercury in the mouths of unsuspecting Americans.

Understanding the effects of amalgam fillings on your body is key to protecting and maintaining your health. Since your teeth are living entities that have direct connections to your circulatory and lymphatic systems, you want to insist that whatever dental products are inserted in your teeth are safe and non-toxic.

Many dentists may "claim" to practice mercury free dentistry but their procedures are a far cry from it.


Asking questions about their dental practices once you are sitting in the dental chair, is not the most prudent way to protect your health. Be prepared and ask questions ahead of time.
Here are a few sample questions to ask your dentist to see if he or she understands the importance of practicing holistic dentistry:

1. Do you believe that amalgams are toxic and create a biological hazard to the body?

2. How do you feel about the relationship between amalgams and various diseases?

3. When you remove amalgams, do you initially use an amalgameter to test the electrical charge on the tooth to see which quadrant needs primary attention?

4. Do you offer a serum compatibility blood test in order to determine what materials will not cause an allergic reaction when you replace the amalgams?

5. Do you believe that there is a tooth-organ relationship through the acupuncture meridian system? In other words, do you believe that a toxic tooth could have an effect on a particular organ?

6. When you remove and replace amalgams, do you use special mercury vapor filters and offer oxygen while performing the procedure? Do you use a rubber dam to protect the mouth from pieces of amalgam that are being removed?

7. Do you belong to a professional organization that supports biological or mercury-free dentistry? What kind of training have you had and when?

Various studies conducted on animals and humans clearly indicate the deposits of mercury in various organs as a result of amalgam fillings in the teeth.

In the analysis of breast cancer tissue, scientist has discovered the accumulation of heavy metals, such as mercury and cadmium in biopsied tissues.

Metals have also been associated with activation of specific estrogen receptors and the increase in breast cancer cells.

Whether you want to simply maintain your health or you are on a healing journey, asking the right questions about the dental procedures that may potentially affect your health is very critical.

Sources:

http://iaomt.org/articles/files/files342/IAOMT%20Fact%20Sheet.pdf
http://www.ncbi.nlm.nih.gov/pubmed/16804515
http://www.toxicteeth.org

About the author:
Dr. Veronique Desaulniers, better known as Dr. V, has maintained successful practices in the Wellness Industry since 1979.
Specializing in Bio-Energetics, Meridian Stress Analysis, Homeopathy, Thermography and Chiropractic, Dr. V brings a unique approach to Health and Wellness.
After personally overcoming Breast Cancer without the use of chemo, radiation or surgery, Dr. V currently helps to empower women about healing and preventing Breast Cancer, naturally.
For more information about Dr. V's personal Cancer Coaching visit http://www.BreastCancerConqueror.com

Learn more: http://www.naturalnews.com/036521_toxic_dentistry_mercury.html#ixzz21GYXq0Xt

Friday, July 20, 2012

Generation X and Climate Change


Generation X Is Surprisingly Unconcerned About Climate Change

ScienceDaily (July 19, 2012) — As the nation suffers through a summer of record-shattering heat, a University of Michigan report finds that Generation X is lukewarm about climate change -- uninformed about the causes and unconcerned about the potential dangers.
"Most Generation Xers are surprisingly disengaged, dismissive or doubtful about whether global climate change is happening and they don't spend much time worrying about it," said Jon D. Miller, author of "The Generation X Report."
The new report, the fourth in a continuing series, compares Gen X attitudes about climate change in 2009 and 2011, and describes the levels of concern Gen Xers have about different aspects of climate change, as well as their sources of information on the subject.
"We found a small but statistically significant decline between 2009 and 2011 in the level of attention and concern Generation X adults expressed about climate change," Miller said. "In 2009, about 22 percent said they followed the issue of climate change very or moderately closely. In 2011, only 16 percent said they did so."
Miller directs the Longitudinal Study of American Youth at the U-M Institute for Social Research. The study, funded by the National Science Foundation since 1986, now includes responses from approximately 4,000 Gen Xers -- those born between 1961 and 1981, and now between 32 and 52 years of age.
Only about 5 percent of those surveyed in 2011 were alarmed about climate change, and another 18 percent said they were concerned about it. But 66 percent said they aren't sure that global warming is happening, and about 10 percent said they don't believe global warming is actually happening.
"This is an interesting and unexpected profile," Miller said. "Few issues engage a solid majority of adults in our busy and pluralistic society, but the climate issue appears to attract fewer committed activists -- on either side -- than I would have expected."
Because climate change is such a complex issue, education and scientific knowledge are important factors in explaining levels of concern, Miller said. Adults with more education are more likely to be alarmed and concerned about climate change, he found. And those who scored 90 or above on a 100-point Index of Civic Scientific Literacy also were significantly more likely to be alarmed or concerned than less knowledgeable adults. Still, 12 percent of those who were highly literate scientifically were either dismissive or doubtful about climate change, Miller found. He also found that partisan affiliations predicted attitudes, with nearly half of liberal Democrats alarmed or concerned compared with zero percent of conservative Republicans.
"There are clearly overlapping levels of concern among partisans of both political parties," Miller said. "But for some individuals, partisan loyalties may be helpful in making sense of an otherwise complicated issue."
Given the greater anticipated impact of climate change on future generations, Miller expected that the parents of minor children would be more concerned about the issue than young adults without minor children.
"Not so," he said. "Generation X adults without minor children were slightly more alarmed about climate change than were parents. The difference is small, but it is in the opposite direction than we expected."
Miller found that Gen X adults used a combination of information sources to obtain information on the complex issue of climate change, with talking to friends, co-workers and family members among the most common sources of information.
"Climate change is an extremely complex issue, and many Generation X adults do not see it as an immediate problem that they need to address," Miller said.
"The results of this report suggest that better educated young adults are more likely to recognize the importance of the problem, but that there is a broad awareness of the issue even though many adults prefer to focus on more immediate issues -- jobs and schools for their children -- than the needs of the next generation. These results will not give great comfort to either those deeply concerned about climate issues or those who are dismissive of the issue."
Story Source:
The above story is reprinted from materials provided byUniversity of Michigan. The original article was written by Diane Swanbrow.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
link:  http://www.sciencedaily.com/releases/2012/07/120719082600.htm

Treatment of Thyroid disorders

Heal your thyroid by banishing inflammation, boosting immunity and improving digestive health

(NaturalNews) Thyroid hormones regulate other hormones, including the adrenal glands' adrenaline production. Thyroid gland hormones also influence cellular metabolism, digestion, libido, and overall energy.

There are three maladies involving the thyroid. Not everyone knows he or she has a thyroid issue even while exhibiting low energy or the inability to lose weight. One is an autoimmune disease and the other two are conditions.

The disease is known as Hashimoto's disease, which actually slowly destroys the thyroid while potentially creating both conditions. In addition to both conditions alternating with Hashimoto's disease, a swollen thyroid or goiter which becomes evident.

The two conditions are hypothyroidism, not enough hormone production or utlization, and the other is hyperthyroidism, or overactive thyroid that causes too much hormone production.



Hypothyroidism is the more common condition with its symptoms of low energy, fatigue, low libido, overweight problems and sensitivity to cold.

Hyperthyroidism can lead to nervousness, restlessness, manic behavior, and difficulty concentrating. Goiter and weight loss can also manifest. Pre-Nazi Germany used sodium fluoride to reduce the excessive hormone production of hyperthyroid patients.

Now, fluoride is in over 75 percent of USA's public water supplies, to keep American citizens dumb and docile with decreased thyroid hormone production.

It's a good idea to eliminate the possibility of Hashimoto's disease before pursuing hypothyroid solutions because the solutions for hypothyroidism are actually dangerous for those with Hashimoto's disease.

Hypothyroidism signs and remedies

Hypothyroidism may be the most common hormonal deficiency in the Western world. It can even occur when the thyroid does produce enough thyroid hormones that are not utilized properly. That's known as thyroid hormone resistance, which produces the same symptoms as hypothyroidism.

Many who think they have fibromyalgia may simply have one of these two manifestations of hypothyroidism. According to Dr. John Lowe, conventional testing can fall short of diagnosing hypothyroidism, especially for those with thyroid hormone resistance.

That's because the T3, T4, and TH hormone counts can appear normal with someone experiencing thyroid hormone resistance. Also, allopathic endocrinologists often have a low expectation of normal. When it comes to remedying thyroid hormone resistance, the high amounts of thyroid hormone Dr. Lowe recommends shock the average endocrinologist.

Dr. Lowe has discovered that treating fibromyalgia complaints the same as hypothyroidism works very well. He uses an additional TRH (thyroid releasing hormone) test with symptom observations.

A simple self-administered test would be to take your temperature immediately upon waking up from a regular night's sleep. A low temperature indicates probable thyroid hormone deficiency, according to Donna Gates of Body Ecology website.

Here is an abbreviated list of other symptoms, most of which resemble fibromyalgia.

* Fatigue mistaken as fibromyalgia
* Unable to lose or stop gaining weight
* Feeling cold easily and often
* Dry skin, eyes, or hair
* Excess muscle tension
* Low immunity
* Low basal body temperature
* Delayed tendon reflex, when the foot returns position slowly after tapping the Achilles heel

Dr. Lowe's complete list of symptoms can be found here: (http://www.drlowe.com/geninfo/hyposymptoms.htm)

It's common for holistic health practitioners to recommend a quality iodine supplement or seaweed consumption. Iodine is thyroid food. They also recommend various natural thyroid hormone supplements.

It makes sense that increased fibromyalgia incidents coincide with a rise in iodine deficiency since iodine was taken out of table salt. Increasing iodine or using thyroid hormone supplements will help a thyroid that's hormone deficient.

Additionally, a comprehensive metabolic approach is required that could also prove helpful for Hoshimoto's disease.

Avoid inflammation causing processed foods and pharmaceutical drugs. Eat organically produced whole vegetables, nuts, legumes, fruits and grains (some say eliminate grains). Hydrate with non-fluoridated water, exercise, and stress less. (http://www.naturalnews.com/032129_fluoridation_intelligence.html)

Sources for this article included:

http://bodyecology.com/articles/low_thyroid_symptoms.php

http://bodyecology.com

http://bodyecology.com

http://thyroid.about.com/cs/hypothyroidism/a/hashivshypo.htm

Learn more: http://www.naturalnews.com/036522_thyroid_inflammation_immunity.html#ixzz21883lXRQ

Cell Division


Cell Division: Puzzling Findings Relating to Centromere Structure Reconciled

ScienceDaily (July 19, 2012) — Scientists at the Stowers Institute of Medical Research have developed an innovative method to count the number of fluorescent molecules in a cluster and then applied the novel approach to settle a debate rampant among cell biologists -- namely, how DNA twists into a unique chromosomal structure called the centromere. Knowing this helps explain how cells navigate the hazards of division and avoid the disastrous consequences of ending up with the wrong number of chromosomes.

A novel microscopy approach -- fluorescence correlation spectroscopy coupled with calibrated imaging -- revealed the number of Cse4 molecules within single centromeric nucleosomes over the course of the cell cycle. (Credit: Courtesy of the Stowers Institute for Medical Research)
Centromeres, which sit at the cross point of the "X" used to represent duplicated chromosomes, are DNA structures that link those duplicated strands when cells are poised to divide. As division starts, a complex cellular machine drags each chromosome to opposite poles of the cell by grabbing onto centromeres and pulling each arm of the "X" into what will become a daughter cell.
Researchers had known that a nucleosome -- a short coil of DNA twisted around a core of proteins -- forms at each centromere. Within the core is a protein, called Cse4 in yeast, that is found only at that location. But the overall architecture of that nucleosome was unknown. Now, Stowers Associate Investigator Jennifer Gerton, Ph.D., has used live cell imaging to reveal constituents of the centromeric protein core. That study is published in the July 20, 2012 of the journal Cell.
"Understanding centromeres is critical because of the role they play in maintaining genomic integrity," says Gerton. "Losing a chromosome is catastrophic for any cell. And if it happens in sperm or egg cells, it is associated with conditions like Down's Syndrome."
Gerton, whose lab uses both the yeast Saccharomyces cerevisiae and mammalian cells to study the mechanics of cell division, says that, previously, people had proposed at least 6 different centromere structures. "What we found is that centromeric nucleosomes change their structure during cell division," she says. "That explained why people had observed different structures. They had likely been looking at different phases of the cell cycle."
"By demonstrating a new method for monitoring the composition of centromeric nucleosomes in living cells, this work helps to resolve some of the controversies surrounding the architecture of the centromere," said Anthony Carter, Ph.D., of the National Institutes of Health's National Institute of General Medical Sciences, which partially funded the research. "The findings have important implications for understanding chromosome segregation, and may lead to insights on how the process goes awry in certain genetic diseases."
Aiding the effort were Stowers Research Advisors Jay Unruh, Ph.D., and Brian Slaughter, Ph.D., who combined two microscopy methods to probe yeast cells engineered to express Cse4 hooked to a green fluorescent protein (GFP) tag. The approach allowed them to track and then count in a living cell the number of Cse4 molecules in a centromeric nucleosome, a question hotly debated in the field.
Slaughter describes the controversy more prosaically: "To a microscopist, the question came down to, how many GFP molecules can we see in a fluorescent dot in the middle of a yeast cell?"
Although the microscopy technology applied -- fluorescence correlation spectroscopy coupled with calibrated imaging -- sounds and is complicated, doing the math required to settle the controversy hardly required a calculator. Yeast cells have 16 chromosomes, each with one centromere. If each centromere contained just one copy of Cse4, then the dot glowing in each cell should be 16 times brighter than a single GFP molecule. And it was. But only right before cells began dividing. Once chromosomes separated and moved to opposite poles of a dividing cell, a stage biologists call anaphase, the intensity of the signal increased.
"To our surprise, we quickly realized that we observed 16 Cse4-GFP molecules early in the cell cycle, and then 32 Cse4-GFP molecules in anaphase," says Slaughter. "That meant the composition of the complex was changing." Further analysis indicated that as cells moved into anaphase a component of the centromeric nucleosome got booted out of the core complex and was replaced by an extra molecule of Cse4, changing both the shape and size of the centromere.
Gerton's team, led by the study's first author Manjunatha Shivaraju, Ph.D., confirmed these findings using additional approaches. They found evidence that two molecules of Cse4 were interacting at the centromere in anaphase, but these interactions were not present during the rest of the cell cycle.
This work will be published back to back with a parallel study of human cells by Yamimi Dalal, Ph.D., of the National Cancer Institute. "The timing of structural changes differs in yeast and human cells," Gerton says, referring to the human study. "And we visualized nucleosomes differently than the Dalal group did. But our conclusions are the same -- that human and yeast centromeres undergo similar dynamic changes with the cell cycle."
Unruh and Slaughter, who developed the microscopy approach used in the study, act as in-house consultants to Stowers investigators about molecular imaging. "Research Advisors provide collaborative support for projects requiring particular expertise," says Slaughter. "We develop novel ways to address questions the PIs are asking." (Stowers also employs research advisors specializing in mathematical modeling and genomics.)
Why such massive effort should be expended on centromere components is evident, given the disastrous consequences of cell division errors. "Most cancer cells are aneuploid," says Shivaraju, referring to a condition in which cells exhibit abnormal numbers of chromosomes. "Knowing that centromeres undergo this structural oscillation could tell us how aneuploidy occurs at a molecular level."
Gerton concurs but also sees the work as reinforcing the utility of yeast as a model organism. "The fact that nucleosome structure is conserved between humans and yeast shows that yeast is a fantastic model for studying molecular mechanisms underlying cell division," she says. "We will continue to use yeast to understand factors that trigger structural changes we see in centromeric nucleosomes."
In addition to Unruh and Slaughter, Mark Mattingly from Stowers and Judith Berman, Ph.D., of the University of Minnesota contributed to this study.
The work was supported by the National Institute of General Medical Science (R01GM080477).
Story Source:
The above story is reprinted from materials provided byStowers Institute for Medical Research, via Newswise.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:
  1. Manjunatha Shivaraju, Jay R. Unruh, Brian D. Slaughter, Mark Mattingly, Judith Berman, Jennifer L. Gerton. Cell-Cycle-Coupled Structural Oscillation of Centromeric Nucleosomes in YeastCell, 20 July 2012 DOI:10.1016/j.cell.2012.05.034